Literature DB >> 3933976

Ventilation studied with circulatory occlusion during two intensities of exercise.

W C Stanley, W R Lee, G A Brooks.   

Abstract

Our purpose was to study the possible role of a pulmonary chemoreceptor in the control of ventilation during exercise. Respiratory gas exchange was measured breath-by-breath at two intensities of exercise with circulatory occlusion of the legs. Eight male subjects exercised on a cycle ergometer at 49 and 98 W for 12 min; circulation to the legs was occluded by thigh cuffs (26.7 kPa) for two min after six min of unoccluded exercise. PETCO2 and VO2 decreased and PETO2 increased significantly during occlusion at both workloads. Occlusion elicited marked hyperventilation, as evidenced by sharp increases in VE, VE/VCO2, and VE/VO2. A sudden sharp increase in PETCO2 was seen 12.3 +/- 0.5 and 6.5 +/- 1.2s after cuff release in all subjects during exercise at 49 and 98 W, respectively. At 49 W a post-occlusion inflection in VE was seen in 7 subjects 21.1 +/- 5.8s after the PETCO2 inflection. Three subjects showed an inflection in VE at 98 W 23.3 +/- 7.5 s after the PETCO2 inflection. There were significant increases in PETCO2, VO2, VCO2 and VE after cuff release. VE mirrored VCO2 better than VO2, post occlusion. On the basis of a significant lag time between inflections in PETCO2 and VE following cuff release, it is concluded that the influences of a pulmonary CO2 receptor were not seen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933976     DOI: 10.1007/bf00426144

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  17 in total

1.  EXPERIMENTS ON NERVOUS FACTORS CONTROLLING RESPIRATION AND CIRCULATION DURING EXERCISE EMPLOYING BLOCKING OF THE BLOOD FLOW.

Authors:  E ASMUSSEN; M NIELSEN
Journal:  Acta Physiol Scand       Date:  1964 Jan-Feb

2.  Computer-based system for analysis of respiratory responses to exercise.

Authors:  D H Pearce; H T Milhorn; G H Holloman; W J Reynolds
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-06

3.  Cardiodynamic hyperpnea: hyperpnea secondary to cardiac output increase.

Authors:  K Wasserman; B J Whipp; J Castagna
Journal:  J Appl Physiol       Date:  1974-04       Impact factor: 3.531

4.  Incorporating the gas analyzer response time in gas exchange computations.

Authors:  R R Mitchell
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-11

5.  The influence of hyperventilation on efferent control of peripheral chemoreceptors.

Authors:  S Majcherczyk; P Willshaw
Journal:  Brain Res       Date:  1977-04-01       Impact factor: 3.252

6.  Mechanism of respiratory responses to intravenous NaHCO3, HCl, and KCN.

Authors:  F Gonzalez; W E Fordyce; F S Grodins
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-12

7.  Ventilation in exercise studied with circulatory occlusion.

Authors:  A J Sargeant; M Y Rouleau; J R Sutton; N L Jones
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-04

8.  Coupling of ventilation to pulmonary gas exchange during nonsteady-state work in men.

Authors:  D H Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-02

9.  Role of neural afferents from working limbs in exercise hyperpnea.

Authors:  M L Weissman; B J Whipp; D J Huntsman; K Wasserman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-08

10.  Cardiorespiratory responses to sudden release of circulatory occlusion during exercise.

Authors:  J R Hildebrandt; R K Winn; J Hildebrandt
Journal:  Respir Physiol       Date:  1979-09
View more
  2 in total

1.  Ventilatory control studied with circulatory occlusion during exercise recovery.

Authors:  W C Stanley; J D Chen; W R Lee; G A Brooks
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

2.  Gait variability is affected more by peripheral artery disease than by vascular occlusion.

Authors:  Hafizur Rahman; Iraklis I Pipinos; Jason M Johanning; Sara A Myers
Journal:  PLoS One       Date:  2021-03-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.